controlled primarily by renin angiotensin system, ACTH and other factors
zona fasciculata
secrete glucocorticoids, adrogens and estrogen
controlled mainly by ACTH
cortisol
CGB
corticosteroid binding globulin
action
Nota:
•Maintains life
•Increases blood glucose – gluconeogenesis.
Also stimulates glycogenolysis.•Increases lipolysis•Decreases protein synthesis in muscle.
Increases protein metabolism in liver.•Anti-inflammatory, immunosuppressive. Decreases response to infections, allergy.•Minor effect on sodium retention and potassium excretion.
zona reticularis
secrete glucocorticoids, adrogens and estrogen
controlled mainly by ACTH
medulla
noradrenaline
secretes catecholamines
under sympatheitc contro
Corticotrophin Releasing Factor/hormone (CRF/CRH)
sythesised mainly in hypothalamus. also in the skin, immune cells and adrenal
glands
identified in 1981
41aa peptide
function: stimulate ACTH production in anterior pituitary
subsequently releasing glucocorticoids from the adrenal gland
receptors: CRH-R1 and CRH-R2
CRH-R1 accounts for all activity in HPA axis
POMC
Pro-opiomelanocortin
synthesised in the pituitary, skin and hypothalmus
cleaved to produce;ACTH, alpha and gamma MSH
MC receptor family detect POMC products
in the skin- involved in pigmentation
POMC mutations connected to obesity via leptin
different actions in different locations depending on how its cleaved and the receptors present
regulation of POMC production
products: ACTH, B-lipotropin, B-MSH and B-endorphin
Gene
Nota:
266 aa,
Located on chr 2p23 •400bppromoter at 5’end followed by 3 exons and 2 introns
•Exon
1 is not translated
•Exon
3 encodes all known peptide products
•POMC
transcribed by a number of tissues in addition to corticotrophs
in the pituitary
•Gene regulation- POMC mRNA levels are increased by CRH and inhibited by
glucocorticoids
regulation of POMC
Nota:
CRH acts via type 1 CRH receptor increases and cAMP levels and increases POMC transcription.
CRH,
arginine vasopressin (AVP) and glucocorticoids all inhibit the mRNA expression
of type 1 CRH receptor
Glucocortiocids stimulates POMC gene expression
ACTH
Adrenocorticotrophic Hormone
acts on adrenal cortical cells to release cortisol (glucocorticoid)
Diurnal rhythm
highest in the morning and lowest at night
produced in a pulsatile manner
Disorders
Cushing's syndrome
Ectopic tumour (15%)
tumours in lung, thymus or pancreas which secrete high levels of ACTH
pituitary (70%)
tumours that secrete high levels of ACTH= high levels of cortisol
adrenal glands(17-19%)
adrenal adenoma or carcinoma resulting in excess cortisol production
ACTH independent Cushing's syndrome
Glucocorticoid excess
ectopic CRH production
other causes
drugs- steroid treatments eg for asthma, arthritis
Alcohol- pseudo-cushing's
symptoms/presentation
osteoporosis
diabetes
myopathy
Nota:
muscular disease in which the muscle fibers do not function resulting in muscle weakness
receding hair
mental disturbance
buffalo hump
acne
truncal obesity
hypertension
Hypopituitarism
causes
post partum haemorrhage
severe head trauma
non secreting pituitary tumours
Diagnosis: low ACTH (undetectable), low cortisol
clinical features
pale patients
coma due to hypoglycaemia because of the increased insulin sensitivity caused by cortisol
deficiency
Treatment
hydrocortisone 2-3 times a day to replace cortisol
levels
hypothalmus connected to pituitary gland by neural stalk
pituitary gland
anterior pituitary
6 types of cells
POMC produced
Mechanisms controlling the HPA axis
Stress increases CRF release
immune suppression
during infection, lymphocytes release interleukins
increases cortisol levels suppress lymphocyte function therefore act to limit immune reaction
Glucocorticoids
the availability of natural glucocorticoids in tissues is regulated by corticosteroid-binding globulin in serum
and by locally expressed 11b-hydroxysteroid dehydrogenase (11b-HSD) [2] enzymes
steroid hormones
cortisol in humans and corticosterone in rodents
cholesterol-derived hormones secreted
by the zona fasciculata of the adrenal glands